Measurements of cholesterol turnover in man have been reported previously (1-3), but a relationship between turnover and cholesterol concentration has not been demonstrated (3). This may be due, in part, to the complex distribution of cholesterol in the body that renders the interpretation of isotopic data difficult.
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Cholesterol exists in the body in a number of separate pools that appear to turn over at differing rates (4) . However, Chobanian and Hollander (5) and Avigan, Steinberg, and Berman (6) have shown that when labeled cholesterol is injected into man or into the rat, equilibration of the total exchangeable cholesterol in the body is eventually achieved and that the subsequent removal of labeled cholesterol from the body represents the turnover of the slowly miscible pool of cholesterol.
Since it seemed probable that cholesterol lowering drugs would affect the rate at which cholesterol is synthesized or excreted, we have made measurements of cholesterol turnover before and after treatment with cholesterol lowering drugs. We have studied the effects of chlorophenoxyisobutyric acid and ethinyl estradiol and have demonstrated that such studies may provide an indication of the mechanism of action of such drugs.
Methods
Ten subjects with coronary heart disease, aged 37 to 62, were studied. Eight had had a myocardial infarction approximately 1 year previously, and two suffered from angina pectoris. Three patients were being treated with anticoagulants. The dietary intake was not re-* Submitted for publication September 8, 1964 ; accepted February 11, 1965. Supported by a grant from the National Heart Foundation of Australia.
stricted, but daily records of all food eaten showed that each subject consumed an acceptably uniform diet throughout the study.
Varying doses, averaging approximately 50 Atc of 4-C"-cholesterol,' were administered to each subject. The cholesterol was dissolved in 0.5 ml ethanol and slowly added to 20 ml of the subject's plasma that had been collected on that day. The plasma was agitated in a water bath at 370 C for 1 hour and then injected intravenously.
Samples of venous blood were collected before breakfast for 4 days and then at weekly intervals for 10 to 14 weeks. The plasma was separated at 4°C and extracted in 20 vol of chloroform: methanol 2: 1 (vol/vol).
Samples were evaporated under nitrogen and separated on silicic acid columns into a fraction containing cholesterol esters, which was eluted with 25 ml 1% diethyl ether in heptane, and a fraction containing free cholesterol, which was eluted with 50 ml chloroform. Contamination of one fraction by the other was less than 1%o. Radioactivity in the eluates was measured in a Tri-Carb liquid scintillation spectrometer using 0.3% diphenyloxazole in toluene as scintillator solvent. Free and esterified cholesterol was measured by the method of Sperry and Webb (7) .
The decline in specific activities of free and esterified cholesterol was plotted semilogarithmically. Specific activity was measured at weekly intervals for at least 6 weeks after isotopic equilibration was reached. The half-time disappearance of the 4-C"-cholesterol was obtained from the linear portion of the specific activity time curve, and the fractional turnover rate was calculated from the equation K = 1/1.44 X tj.
After the cholesterol turnover rate had been deter- 4 ). In the subject who did not receive CPIB or estrogens, and in the subject in whom CPIB failed to lower the serum cholesterol (Figure 1 ), the rate of fall in specific activity remained constant for up to 18 weeks, when the studies were terminated.
The plasma cholesterol ester specific activity was initially lower than that of free cholesterol and rose for several days. In general the cholesterol ester specific activity curve crossed the free cholesterol curve at its peak. This peak was reached on the third day in eight studies and between the third and seventh day in the remaining two. The specific activities of free and esterified cholesterol were virtually identical after the first week, Fractional turnover rates and serum cholesterol. The serum cholesterol levels, the specific activities on day 30, and the fractional turnover rates are shown in Table I . The calculations of fractional turnover rates were made from the linear portion of the curve, generally from the end of week 4 to the end of week 9.
The fractional turnover rates varied from 0.015 to 0.025 per day. The correlation betwen fractional turnover rate and serum cholesterol concentration was found to be significant (p = < 0.05).
The specific activities on day 30 have been corrected to a dose of 106 cpm per kg. (Isotopic equilibration of the exchangeable pool of cholesterol appeared to have been achieved in every study by day 30.) There was no correlation between specific activity on day 30 and serum cholesterol concentration.
Effect of CPIB. CPIB produced a fall in cholesterol concentration that exceeded 5% in five of six subjects (Table II) . The figures represent the means of the determinations made during the measurements of fractional turnover rate before and during treatment. The decline in esterified cholesterol in the five subjects who responded varied from 19 to 33 (mean 25) %o and that of free cholesterol from 6 to 22 (mean 15) %o. The fall in esterified cholesterol was invariably greater than that in free cholesterol.
In the patient who did not respond to CPIB the fractional turnover rate remained unchanged ( Figure 1 , Table II ). In the other five subjects there was a decrease in the rate of fall in specific activity, and this effect was more pronounced on cholesterol esters ( turnover rate for the purpose of illustrating the direction of change in turnover. Effect of ethinyl estradiol. The administration of this drug to three subjects produced decrements in plasma free and esterified cholesterol concentrations (Table III, Figure 4 ). The falls in esterified cholesterol were 16, 21, and 13% and those in free cholesterol 20, 23, and 16%o, respectively.
There was a marked increase in the rates of fall in specific activity that was of similar magnitude in all three subjects (Table III, Figure 4 ). These affected free and esterified cholesterol to a similar degree.
Discussion
These studies confirm previous observations that cholesterol turnover represents the sum of the turnovers of a number of pools but that isotopic equilibration in man is generally reached by the end of the first month (3). Chobanian and Hollander (5) have demonstrated this more directly by measuring the specific activities of cholesterol in many tissues after the injection of C14-cholesterol. They were able to show that the miscible pool of cholesterol in man includes the cholesterol in all the body tissues outside the nervous system and that this pool is in isotopic equilibrium by the end of the first month. We have therefore assumed that the rate of disappearance of C'4-cholesterol from the plasma from week 4 to week 9 represents the turnover of the miscible pool of cholesterol. The fractional turnover rates of C14-cholesterol derived from the equilibrated portion of the curves varied from 0.015 to 0.025 per day. However, in nine of the ten studies the range of fractional turnover rates was between 0.015 and 0.020 per day indicating much less variation than in the study of Chobanian, Burrows, and Hollander (3). This may be due to the greater homogeneity of our group of subjects. The constant rate of fall in specific activity in all our subjects, which was followed in some for as long as 18 weeks, excludes the possibility that equilibration had not been reached at the time when these calculations were made.
Our finding of a significant direct relationship between serum cholesterol concentration and fractional turnover rate is at variance with that reported by Chobanian and associates (3) and may be due to the heterogeneity of their group of subjects. Our finding cannot be interpreted adequately without an accurate measurement of pool sizes and turnover rates. Since the fractional (12) . These changes were not confined to cholesterol esters, and both triglycerides and phospholipids were affected to a lesser extent. The significance of this is obscure.
Since this study was completed, abstracts of two other studies have been published that are consistent with our observations. Gould, Avoy, and Swyryd (13) have demonstrated that synthesis of cholesterol from acetate was diminished in livers of CPIB fed rats. Duncan, Best, and Despopoulos (14) have found a decrease in the rate of lipoprotein secretion by livers of CPIB-fed rats.
The mode of action of estrogens appears to be different. The falls in cholesterol concentration were accompanied by increased rates of fall in specific radioactivity. This is most readily explained by an increase in the total turnover rate. These findings are consistent with the studies of Kritchevsky, Staple, Rabinowitz, and Whitehouse (15) , who showed that cholesterol oxidation was greater with liver mitochondrial preparations of female than of male rats. Moreover, the administration of estrogens to male rats increased the rate of oxidation. Since synthesis of cholesterol by liver homogenates was also greater in female rats, it would appear that, in the rat, estrogens increase the turnover rate of cholesterol.
Summary
The fractional turnover rates of cholesterol were measured in ten subjects with coronary heart disease. C14-cholesterol was complexed with plasma lipoproteins in vitro and injected intravenously. Isotopic equilibration was reached after 4 weeks, and measurement of the rate of removal of labeled cholesterol was then continued for 2 to 3 months.
A significant relationship was found between fractional turnover rate and serum cholesterol concentration.
When determinations of initial fractional turnover rates were completed, six subjects were treated with chlorophenoxyisobutyric acid and three others with ethinyl estradiol. Both drugs produced falls in plasma cholesterol concentration. The administration of ethyl chlorophenoxyisobutyrate (CPIB) produced a decrease in the rate of fall of cholesterol specific activity indicating a probable inhibition of cholesterol or lipoprotein synthesis. On the other hand, treatment with ethinyl estradiol resulted in an increase in the rate of fall of cholesterol specific activity indicating increased turnover or catabolism.
